This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Fero Industries, Inc. Announces Interim Chief Financial Officer

CALGARY, Alberta, Jan. 22, 2013 /PRNewswire/ -- Fero Industries, Inc. (OTC: FROI), the exclusive producer, marketer & distributor of Sucanon®, an oral type-2 Diabetes treatment, announced today that the company has hired Barry Hall, through his consulting company Carlaris LV Inc., as Interim CFO. Mr. Hall is the former CFO of EarthLink and brings extensive experience in accounting, corporate governance and strategic planning to the company.

"Barry's high level of experience is exactly what we need to move Fero Industries forward," commented Luis Lopez, Fero Industries Chief Executive Officer. "We are continuously working to position the company favorably as a public entity, and we understand that it is essential to prepare for an eventual audit which will lead to up-listing on the exchange. Barry's first project for Fero will be to file our unaudited financials on OTC Markets, and we are excited at the progress that can be made with someone like him on our team."

Barry Hall states, "I'm very eager to begin working with Fero and their exceptional Type II diabetes drug, Sucanon®. I believe strongly in the company and their mission, and am looking forward to helping them achieve their financial objectives."

Barry Hall has over 35 years of business experience that combines a strong financial background with a deep knowledge and practice of general management. He has been a CEO, COO and CFO for a variety of publicly and privately traded Internet, High Technology, and Telecommunications companies.  He was the Founder and CFO of Thwapr Inc. a mobile video technology company; the Chief Financial Officer of EarthLink, Inc. who led its IPO; Chairman and CEO of CalAmp Corp, where he developed and directed the business strategy and marketing plan that turned this publicly held manufacturer of satellite television and wireless cable amplifiers from near bankruptcy, to the #10 small corporation in the United States (Business Week).

Barry holds an MBA and a BA in Mathematics, and served in the United States Marine Corps as a Tank Platoon Commander, advancing to the rank of Captain prior to his discharge.

About Sucanon ®

Sucanon ® is one of only three approved drugs in the multi-billion dollar market for a class of diabetic medications called "insulin sensitizers".  Pre-clinical and clinical studies show that Sucanon ® and other insulin sensitizers lower a patient's blood sugar by increasing the muscle, fat and liver's sensitivity to the body's own naturally produced insulin.  Sucanon ® has been approved for prescription sale in China and Peru.  Sucanon ® is also approved as an OTC treatment for Type-II diabetes by regulatory authorities in Mexico, and is distributed there under an exclusive agreement with Merck S.A. de C.V.

For further information regarding Sucanon ®, please visit the Fero Industries Inc. website at www.feroindustries.com.

About Fero Industries Inc.

Fero Industries, Inc. (OTC: FROI) is focused on diabetes prevention and treatments.  The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon ®, an oral treatment for Type-II diabetes.  Sucanon ® is a member of a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.  Fero's strategy is to increase awareness, acceptance, and distribution of Sucanon ® globally.

For investor relations contact:

Michael Irving Paramount Advisors, LLC(407) 878-5462

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs